Table 5. Prevalence Ratios for Amount Smoked from Univariate and Multivariate Analysis among HIV-seropositive Participants.

	Univariate Analysis		Multivariate Analysis
	HIV-seropositive	p-value	HIV-seropositive	p-value
Age	0.997 (.996-.997)	<0.0001	0.998 (.997-.999)	0.018
Race
White, non-Hispanic	Reference		Reference
Black, non-Hispanic	0.93 (0.91-0.95)	<0.0001	0.94 (0.91-0.97)	0.0001
Other	0.91 (0.89-0.94)	<0.0001	0.89 (0.85-0.92)	<0.0001
Education
High School Diploma or Less	1.10 (1.07-1.13)	<0.0001	1.09 (1.05-1.14)	<0.0001
Some College or College Degree	1.05 (1.03-1.08)	<0.0001	1.04 (1.01-1.07)	0.008
Graduate Work or More	Reference		Reference
Enrolled after 2001	0.95 (0.93-0.97)	<0.0001	1.02 (0.99-1.01)	0.143
Unemployed	1.02 (1.00-1.05)	0.028	1.01 (0.98-1.48)	0.565
Site
Baltimore/Washington DC	Reference		Reference
Chicago	1.00 (0.97-1.03)	0.860	1.00 (0.96-1.03)	0.891
Los Angeles	1.00 (0.97-1.02)	0.720	0.98 (0.95-1.01)	0.140
Pittsburgh	1.05 (1.02-1.09)	0.001	1.02 (0.98-1.07)	0.245
Alcohol use
None	Reference		Reference
Low - Moderate	1.03 (1.01-1.06)	0.013	1.02 (0.99-1.05)	0.062
Moderate – Heavy	1.06 (1.01-2.68)	0.016	1.05 (1.01-1.10)	0.02
Binge	1.09 (1.04-1.13)	<0.0001	1.08 (1.02-1.04)	0.0002
Marijuana use	1.07 (1.05-1.08)	<0.0001	1.07 (1.05-1.08)	0.067
Hospitalization in the last 6 months	0.998 (.986-1.01)	0.756	-	-
Depressed Symptoms	0.95 (0.94-1.06)	<0.0001	1.02 (0.99-1.45)	0.142
CD4+ T-cell count (cells/μl)
>500	Reference		Reference	-
201-500	0.98 (.966-1.00)	0.101	-	-
≤ 200	0.99 (.972-1.00)	0.156	-	-
HAART Use
No Therapy	1.04 (1.02-1.06)	<0.0001	1.02 (0.99-1.04)	0.245
Monotherapy	1.01 (0.99-1.03)	0.421	0.96 (0.92-0.99)	0.132
Combined Therapy	0.99 (0.96-1.02)	0.310	1.06 (0.99-1.14)	0.094
Potent ART	Reference		Reference
Viral Load	1.07 (1.05-1.08)	<0.0001	1.01 (1.00-1.02)	0.02